These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23726899)

  • 21. Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.
    Balhara YP
    J Opioid Manag; 2013; 9(4):237. PubMed ID: 24380101
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of opioid overdose and response in a high-risk community corrections sample: a preliminary study.
    Cropsey KL; Martin S; Clark CB; McCullumsmith CB; Lane PS; Hardy S; Hendricks PS; Redmond N
    J Opioid Manag; 2013; 9(6):393-400. PubMed ID: 24481927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR; Lea T; Sheridan J
    Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methadone diversion as a protective strategy: the harm reduction potential of 'generous constraints'.
    Harris M; Rhodes T
    Int J Drug Policy; 2013 Nov; 24(6):e43-50. PubMed ID: 23199896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healthcare costs and nonadherence among chronic opioid users.
    Leider HL; Dhaliwal J; Davis EJ; Kulakodlu M; Buikema AR
    Am J Manag Care; 2011 Jan; 17(1):32-40. PubMed ID: 21348566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to Chandler et al., Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods.
    Valentine K; Treloar C
    Int J Drug Policy; 2013 Nov; 24(6):e87-8. PubMed ID: 23931956
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of methadone maintenance on health utility, health care utilization and expenditure in drug users with HIV/AIDS.
    Tran BX; Nguyen LT
    Int J Drug Policy; 2013 Nov; 24(6):e105-10. PubMed ID: 23937854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dealing with aggressive methadone patients in community pharmacy: a critical incident study.
    Irwin A; Laing C; Mearns K
    Res Social Adm Pharm; 2012; 8(6):542-51. PubMed ID: 22381914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence.
    Monte AA; Mandell T; Wilford BB; Tennyson J; Boyer EW
    J Addict Dis; 2009 Jul; 28(3):226-31. PubMed ID: 20155591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Responses of state Medicaid programs to buprenorphine diversion: doing more harm than good?
    Clark RE; Baxter JD
    JAMA Intern Med; 2013 Sep; 173(17):1571-2. PubMed ID: 23877740
    [No Abstract]   [Full Text] [Related]  

  • 31. The Impact of Misuse and Diversion of Opioid Substitution Treatment Medicines: Evidence Review and Expert Consensus.
    Reimer J; Wright N; Somaini L; Roncero C; Maremmani I; McKeganey N; Littlewood R; Krajci P; Alho H; D'Agnone O
    Eur Addict Res; 2016; 22(2):99-106. PubMed ID: 26426530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Opiate substitution programs: last chance programs or deal for quality of life?].
    Manghi R; Soulignac R; Zullino D
    Rev Med Suisse; 2013 Sep; 9(398):1669-71. PubMed ID: 24164016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid dependence - management in general practice.
    Frei M
    Aust Fam Physician; 2010 Aug; 39(8):548-52. PubMed ID: 20877747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The disparate treatment of medications and opiate pain medications under the law: permitting the proliferation of opiates and limiting access to treatment.
    Ferrara MM
    Seton Hall Law Rev; 2012; 42(2):741-67. PubMed ID: 22708140
    [No Abstract]   [Full Text] [Related]  

  • 35. Is opioid substitution treatment beneficial if injecting behaviour continues?
    Gjersing L; Bretteville-Jensen AL
    Drug Alcohol Depend; 2013 Nov; 133(1):121-6. PubMed ID: 23773951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sourcing of opioid analgesics for nonmedical use: Are veterinarians the latest frontier?
    Russell C; Fischer B; Fidalgo TM
    J Opioid Manag; 2018; 14(2):77-79. PubMed ID: 29733092
    [No Abstract]   [Full Text] [Related]  

  • 37. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The trajectory of methadone maintenance treatment in Nepal.
    Ambekar A; Rao R; Pun A; Kumar S; Kishore K
    Int J Drug Policy; 2013 Nov; 24(6):e57-60. PubMed ID: 23845916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.
    Madden A; Lea T; Bath N; Winstock AR
    Drug Alcohol Rev; 2008 Nov; 27(6):671-8. PubMed ID: 19378450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescription opioid misuse: characteristics of earliest and most recent memory of hydromorphone use.
    Fulton HG; Barrett SP; Stewart SH; Macisaac C
    J Addict Med; 2012 Jun; 6(2):137-44. PubMed ID: 22105062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.